Cargando…
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
Chemoresistance is a daunting challenge to the prognosis of patients with breast cancer. Signal transducer and activator of transcription (STAT) 5a plays vital roles in the development of various cancers, but its function in breast cancer is controversial, and its role in chemoresistance in breast c...
Autores principales: | Li, Zhaoqing, Chen, Cong, Chen, Lini, Hu, Dengdi, Yang, Xiqian, Zhuo, Wenying, Chen, Yongxia, Yang, Jingjing, Zhou, Yulu, Mao, Misha, Zhang, Xun, Xu, Ling, Ju, Siwei, Shen, Jun, Wang, Qinchuan, Dong, Minjun, Xie, Shuduo, Wei, Qun, Jia, Yunlu, Zhou, Jichun, Wang, Linbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320598/ https://www.ncbi.nlm.nih.gov/pubmed/34336684 http://dx.doi.org/10.3389/fonc.2021.697950 |
Ejemplares similares
-
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
por: Li, Zhaoqing, et al.
Publicado: (2022) -
Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient
por: Li, Zhaoqing, et al.
Publicado: (2021) -
Targeting ferroptosis in breast cancer
por: Li, Zhaoqing, et al.
Publicado: (2020) -
Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis
por: Chen, Cong, et al.
Publicado: (2022) -
Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer
por: Yang, Jingjing, et al.
Publicado: (2021)